PubMed Health⌕ Search

Biomedical subjects

Gerald A Beathard

Publications and source records attributed to Gerald A Beathard.

5 recordsLinked to original sources

Aggressive treatment of early fistula failure.

BACKGROUND: Fistula failure has been classified as early and late. Early failure refers to those cases in which the arteriovenous (AV) fistula never develops to the point that it can be used or fails within the first 3 months of usage. It has been common practice to abandon these early failures; however, aggressive evaluation and treatment of early fistula failures has been shown to result in the salvage of a large percentage. The two most common causes of the failure seen at this time are juxta-anastomotic stenosis (JAS) and the presence of accessory veins. Both of these can be easily diagnosed by physical examination. This study reports the results of early fistula failure managed aggressively in an attempt at salvage. METHODS: These studies were conducted in six freestanding outpatient interventional facilities in different regions of the United States. Interventional nephrologists are employed at all of these facilities except one that is operated by an interventional radiologist. Each patient was first evaluated angiographically to identify the anatomy of their AV fistula and detect abnormalities that might be present. Stenotic lesions were then treated with angioplasty and accessory veins thought to be significant were obliterated. All patients were then followed to determine if the fistula was usable for dialysis. RESULTS: One hundred patients were identified that met the definition of early failure. Venous stenosis was present in 78% of these cases. In 43% of the cases, the lesion was in the JAS location. In 15%, this was the only lesion present. In 24%, it was associated with an accessory vein, in 6% with a proximal stenosis, and in 4% with both. A proximal stenosis lesion was present in the fistula in 36%. In 6%, it was associated with an accessory vein, in 6% with a JAS, and in 4% with both. The definition of arterial anastomosis stenosis was met in 38% of the cases. This was always in association with JAS. In four cases, a stenotic lesion was present in the artery above the anastomosis. An accessory vein was present in 46% of the cases. In 12% of the cases, this was the only lesion present. In 24% of the cases, this anomaly was associated with JAS, in 6% with proximal stenosis, and in 4% with both. Angioplasty was performed to treat venous stenosis in 72% of the cases with a 98% success rate. Angioplasty of the arterial anastomosis was performed in 38 cases with a 100% success rate. Accessory vein obliteration was performed in 46% of the patients with a 100% success rate. The overall complication rate in this series was 4%, of these 3% were minor and 1% were major. It was possible to initiate dialysis using the fistula in 92% of the cases. Actuarial life-table analysis showed that 84% were functional at 3 months, 72% at 6 months, and 68% at 12 months. CONCLUSION: If correctable pathology is detected in patients with early fistula failure, the incidence of correctable lesions is relatively high and an aggressive therapeutic approach can be expected to have a high yield.

Aged↗

Integrated vascular access management.

Nephrologists need to deal with the problem of vascular access management in the same manner as the other major problems that affect our dialysis patients. We need to become experts in vascular access and we need to occupy a pivotal position in directing the decisions that are made that affect dialysis patient welfare. An integrated vascular access management strategy is required. Optimally, there should be four components to this strategy - evidence-based policies and procedures, a dedicated vascular access facility, committed vascular access surgeons and the availability of committed vascular access interventionalists. In many respects this is the approach that offers the best in quality of patient care and is also the most economic to deliver.

Catheterization↗

Angioplasty for arteriovenous grafts and fistulae.

The technique of percutaneous transluminal angioplasty (PTA) has become routinely used in the management of hemodialysis access dysfunction. It is used for the management of problems that affect both AVF and grafts. In the case of fistulae, it is used for treatment of early failure caused by juxta-anastomotic stenosis and late failure related to venous stenosis. In the case of AVGs, it is used primarily for the management of venous stenosis secondary to neointimal hyperplasia. The technique has been shown to be safe, easily performed, and effective. Details of the procedure, supplies used, complications and their management, and results are reviewed in detail.

Angioplasty, Balloon↗

Management of complications of endovascular dialysis access procedures.

Endovascular procedures are becoming the standard of care for the management of hemodialysis (HD) vascular access dysfunction. As with any type of medical procedure, these techniques result in procedure-related complications. The expected frequencies are low. The most frequent procedure-related complication seen in association with angioplasty that dictates the need for intervention is tearing of the vein or vein rupture. The clinical significance of this complication is variable, ranging from none to disaster for the access. The difference lies in the severity of the tear. Management depends on the clinical presentation, ranging from symptomatic measures alone to the need to occlude the graft. Since endovascular thrombectomy is a combined procedure including angioplasty, all of the complications of that procedure can occur with this procedure as well. The major unique procedure-related complication requiring interventional therapy is the occurrence of a symptomatic peripheral artery embolus. This complication can generally be managed successfully by mechanical endovascular means. It is essential that the interventionalist be prepared to manage these complications appropriately when they are encountered.

Angioplasty↗

Catheter management protocol for catheter-related bacteremia prophylaxis.

This study reports a prospective observational study in which an infection prophylaxis protocol based on the National Kidney Foundation's Kidney Disease Outcomes and Quality Initiative (NKF-K/DOQI) guideline 15 describing guidelines for the care of the tunneled dialysis catheter at the time of catheter hook-up for dialysis was used. Catheter-related bacteremia (CRB) incidence data were collected for a 24-month study period and compared to retrospectively collected control data for the immediately preceding 9 months in the same patient population under the same conditions except for the prophylaxis protocol. The incidence of CRB fell from an average level of 6.97 per 1,000 catheter-days during the control period to an average of 1.68 during the study period. This change was statistically significant. Although the lowered incidence required 6 months to reach its maximum, the decreased infection rate was sustained. The average incidence during the last 18 months of the study period was 1.28 per 1,000 catheter-days. Staff compliance with the protocol did require repetitive education and assessment.

Bacteremia↗